To our knowledge, this is the first study to demonstrate the prognostic role of changes in CD8+ TIL levels, FOXP3+ TIL levels and the CFR in patients failing to achieve pCR following NAC in all breast cancer subtypes. Here, FOXP3 is linked to breast carcinoma.